Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CL(pro)): an in silico screening of alkaloids and terpenoids from African medicinal plants

The novel coronavirus disease 2019 (COVID-19) caused by SARS-COV-2 has raised myriad of global concerns. There is currently no FDA approved antiviral strategy to alleviate the disease burden. The conserved 3-chymotrypsin-like protease (3CL(pro)), which controls coronavirus replication is a promising...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Biomol Struct Dyn
Main Authors: Gyebi, Gideon A., Ogunro, Olalekan B., Adegunloye, Adegbenro P., Ogunyemi, Oludare M., Afolabi, Saheed O.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7256353/
https://ncbi.nlm.nih.gov/pubmed/32367767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1764868
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados